Details for 2020179085

Up to date per 13.05.2026

Actions

Title / Product Name

(E)-2,4,6-TRIMETHOXYSTYRYL-3-[(CARBOXYMETHYL)AMINO]-4-METHOXYBENZYLSULPHONE ZUR VERWENDUNG IN DER BEHANDLUNG VON ZUSTÄNDEN RESULTIEREND AUS ABNORMALER ZELLPROLIFERATION

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2020179085

EP Publication Number

3733163

E-Number

1496435

Language

PCT Number

Publication Date

04.11.2020 A

08.06.2022 B1

Registration Date

08.06.2022

AT Publication Date

15.06.2022

Application Date

13.04.2018

Registration Number

Priorities

13.04.2017

201762485355 P

28.08.2017

201715688320

28.08.2017

PCT/US2017/048890

IPC

A61K 9/00 20060101AFI20200904BHEP

Maximum Duration of Protection

13.04.2038

Owner

Onconova Therapeutics, Inc.12 Penns Trail Newton, PA 18940US

Representative

No representatives present

Inventor

MANIAR, Manoj46750 Sentinel Drive Fremont, CA California 94539US